Files in This Item:
   
Thumbnail16_1_2010_0089_0093.pdf

View/Open

Title: Evaluation of intralesional 0.2% ciprofloxacin as a treatment for cutaneous leishmaniasis
Authors: Al Hamdi, K.I.
Awad, A.H.
Moker, H.M.
Issue Date: 2010
Language: English
Abstract: Although cutaneous leishmaniasis lesions usually heal spontaneously they cause unsightly scarring. This study evaluated a possible new therapy in 38 patients, with 70 lesions, randomly assigned to intralesional injection of ciprofloxacin [0.2%] or intralesional sodium chloride hypertonic solution [7%]. After excluding patients who defaulted on treatment, lesions assigned to sodium chloride treatment [n = 21] were completely healed [with or without scarring] in 76.2% of cases, and, when a scar remained, the scar size was reduced 66.0% compared with the original lesion. Lesions assigned to ciprofloxacin [n = 27] showed an 81.5% healing rate with an average scar size reduction of 68.6%. Intralesional 0.2% ciprofloxacin was as effective as hypertonic saline in the treatment of cutaneous leishmaniasis infection
Description: 89-93
Keywords: Ciprofloxacin
Sodium Chloride
Treatment Outcome
Subject: Leishmaniasis, Cutaneous
URI: http://www.who.int/iris/handle/10665/117823
ISSN: 1020-3397
Other Identifiers: http://applications.emro.who.int/emhj/V16/01/16_1_2010_0089_0093.pdf
Appears in Collections:EMRO Journal Articles (EMHJ)



Items in WHO IRIS are protected by copyright, with all rights reserved, unless otherwise indicated.